LEUKOSEP – SOLX B ADDITIVE SOLUTION (Haemonetics Manufacturing Inc)
Welcome to the PulseAid listing for the LEUKOSEP – SOLX B ADDITIVE SOLUTION drug offered from Haemonetics Manufacturing Inc. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Haemonetics Manufacturing Inc |
| NON-PROPRIETARY NAME: | SOLX B ADDITIVE SOLUTION |
| SUBSTANCE NAME: | DEXTROSE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-05-15 |
| END MARKETING DATE: | 0000-00-00 |
LEUKOSEP – SOLX B ADDITIVE SOLUTION HUMAN PRESCRIPTION DRUG Details:
| Item Description | LEUKOSEP – SOLX B ADDITIVE SOLUTION from Haemonetics Manufacturing Inc |
| LABELER NAME: | Haemonetics Manufacturing Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1.78(g/30mL) |
| START MARKETING DATE: | 2013-05-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 53157-301_795f1082-9ede-47cb-9a22-5092787ecbb3 |
| PRODUCT NDC: | 53157-301 |
| APPLICATION NUMBER: | NDA110059 |
Other DEXTROSE Pharmaceutical Manufacturers / Labelers:
